Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesIdentification of a novel CYP2C19-mediated metabolic pathway of S-citalopram in vitro
Drug Metabolism and Disposition, 10/05/09
Rudberg I et al. – Identification of SCIT PROP as a metabolic pathway catalyzed by CYP2C19 might explain why impaired CYP2C19 activity has substantially larger effect on SCIT exposure than estimated from in vitro data based solely on formation of SDCIT.
Related Articles
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 84%
Use of Antidepressants for Management of Hot Flashes
Pharmacotherapy, 10/27/09
Relevance Score: 80%
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Biological Psychiatry, 10/23/09
Relevance Score: 80%
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Relevance Score: 77%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Expectations, validity, and reality in pharmacogenetics
Journal of Clinical Epidemiology, 12/10/09
Inhibitory effects of 1,3-thiazine derivatives on melanogenesis
Journal of Pharmacy and Pharmacology, 12/10/09
Review: physical chemistry of solid dispersions
Journal of Pharmacy and Pharmacology, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor